An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

Study Site, Saida

Study Site 4, Sofia

Study Site, Rousse

Study Site, Varna

Study Site, Rochester

Study Site, Wilkes-Barre

Study Site, Philadelphia

Study Site, West Reading

Study Site, Newark

Study Site, Winston-Salem

Study Site, Memphis

Study site, Lexington

Study Site, Minneapolis

Study Site, Duluth

Study Site, Houston

Study site, Bryan

Study Site, Austin

Study Site, El Paso

Study Site, Albuquerque

Study Site 1, Moscow

Study Site 2, Moscow

Study Site, Saint Petersburg

Study Site, Timișoara

Study Site, Kazan'

Study Site, Novosibirsk

Study Site 2, Barnaul

Study Site, Boston

Study Site 1, Minsk

Study Site 2, Minsk

Study Site, Beirut